We only have this paper's title and publication details.
Read it at the sourceBevacizumab may significantly increase the risk of serious hemorrhage in cancer patients.
No takes yet. Share an insight, caveat, or question.
Hapani et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: